Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127025931 | 12702593 | 1 | I | 20160708 | 20160709 | 20160831 | 20160831 | PER | US-JNJFOC-20160708184 | JANSSEN | 43.77 | YR | A | M | Y | 120.20000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127025931 | 12702593 | 1 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | N | FKS03MB | 125261 | 90 | MG | SOLUTION FOR INJECTION | ||||||
| 127025931 | 12702593 | 2 | C | OTEZLA | APREMILAST | 1 | Unknown | 0 | 30 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127025931 | 12702593 | 1 | Psoriasis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127025931 | 12702593 | Incorrect product storage | |
| 127025931 | 12702593 | Syringe issue | |
| 127025931 | 12702593 | Underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127025931 | 12702593 | 1 | 20160708 | 0 | ||
| 127025931 | 12702593 | 2 | 20160707 | 0 |